Earnings

In December, the firm finished a public offering for proceeds of $3.2 million

The firm reported its third-straight quarter of positive adjusted EBITDA

The company will be EBITDA-positive by Q3, CEO says

For better or for worse, the firm's focus appears to be moving further away from cannabis sales

A recent capital raise has boosted the firm's cash position

The company is also making a number of new changes to its top management

While it's now expanded to new markets, almost all of the firm's 2020 sales were in Quebec

After too-bleak an outlook in legal weed, the firm says it can better secure shareholder value via pharmaceutical development

The firm says opportunities lie in new genetics and its EU GMP-certified operations in Portugal

Early feedback on the firm's cannabis products has been strong

TGOD says new acquisitions and marketing partnerships will help boost sales

In October, the province started fulfillment and delivery from its distribution centre in St. John's

Company executives say the quarter was important for securing future growth

The firm's new CEO looks to be off to a strong start

Growth was driven by medical cannabis clinic operations in Colombia and Germany, company says

But other profitability metrics lagged in the quarter

The firm says it had its first EBITDA-profitable month in September

Delays to store openings and 'unforeseen' regulatory issues have caused the firm to rein in its earnings projections for the year

But net income soared due to a US$69M value gain on warrants

The firm blamed the drop in part on 'seasonal weakness'

But concerns remain around its significant debt pile and an inability to pay it off

The firm upped Q3 revenue by 17% but tallied a $13.5M loss

Particularly the firm's new retail acquisition is turning a profit

The firm is selling in 12 international markets and has added eight more product listings in Canada

The firm is projecting revenues to rise another 9% in Q4

The leading US weed firm continues to post solid growth and fundamentals

The company says a majority of new sales growth is coming from its focus on medical cannabis

Net loss ballooned 507% to US$59 million this fiscal period due to rising expenses

Company stock soared 12% on Tuesday

Q2 revenue dipped 6% to $146M

The firm says it's looking for solutions to debt obligations it continues to be in default of

The firm's beverage sales are up 66% and the rest of its adult-use segment grew 31% this quarter

Legal weed sales went up 13% after little growth reported in the previous quarter

The firm said Ontario revenue slowed in the second half of the fiscal year due to more stores and value players entering the market

With an average price per gram of $6.50, its prices are competitive with the illicit market, says the NSLC

With a handful of retailers and producers now online, the territory is continuing to work on bringing more consumers in

The Ontario Cannabis Store says legal products account for almost half of provincial sales

The firm is set to acquire Citizen Stash and Verse in the near future

While Canadian recreational sales were down, sales were boosted by the firm's first international shipment to Israel

As his firm struggles to outshine his competition, CEO Irwin Simon says he'll win over more customers by educating them on his brands in stores